Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.052 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.055 | 0.7 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.054 | 0.8 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |